Membrane-targeted photodynamic mechanisms of methylene violet 3RAX in melanoma models

Thais Soares de Oliveira1, Mirella Boaro Kobal1, André Satoshi Ferreira1

  • 1São Paulo State University (UNESP), School of Sciences, Humanities and Languages, Assis, SP 19806-900, Brazil.

Insights

Methylene violet 3RAX (MV) shows promise for photodynamic therapy (PDT) against melanoma. Upon light activation, MV effectively induces cancer cell death via apoptosis and destabilizes cell membranes.

Area of Science:

  • Biochemistry
  • Photochemistry
  • Dermatology

Background:

  • Melanoma is an aggressive skin cancer with limited treatment options.
  • Photodynamic therapy (PDT) presents a less invasive therapeutic approach.
  • Phenazine dyes are being investigated as photosensitizers for PDT.

Purpose of the Study:

  • To evaluate methylene violet 3RAX (MV) as a photosensitizer for melanoma PDT.
  • To investigate MV's interaction with melanoma cell lipid membranes.
  • To elucidate the mechanism of MV-induced cell death.

Main Methods:

  • In vitro cytotoxicity assays with melanoma cell lines (A375, SH-4).
  • Flow cytometry to determine cell death pathways.
  • Langmuir monolayer studies to analyze MV-lipid interactions.
  • Spectroscopic analysis to assess membrane damage.

Main Results:

  • MV demonstrated light-dependent cytotoxicity against melanoma cells.
  • Apoptosis was identified as the primary cell death mechanism.
  • MV adsorbed to anionic lipid head groups, particularly phosphates.
  • Photoactivation induced membrane destabilization via lipid peroxidation.

Conclusions:

  • MV is a potent photosensitizer for melanoma PDT.
  • MV's mechanism involves membrane interaction and photo-induced damage.
  • MV acts as a molecular probe for studying membrane dynamics.

Related Concept Videos